214 related articles for article (PubMed ID: 1382424)
1. A comparison of drug binding sites on mammalian albumins.
Panjehshahin MR; Yates MS; Bowmer CJ
Biochem Pharmacol; 1992 Sep; 44(5):873-9. PubMed ID: 1382424
[TBL] [Abstract][Full Text] [Related]
2. Drug binding sites on chicken albumin: a comparison to human albumin.
Rajaian H; Symonds HW; Bowmer CJ
J Vet Pharmacol Ther; 1997 Dec; 20(6):421-6. PubMed ID: 9430764
[TBL] [Abstract][Full Text] [Related]
3. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
Panjehshahin MR; Bowmer CJ; Yates MS
Biochem Pharmacol; 1991 Apr; 41(8):1227-33. PubMed ID: 1706921
[TBL] [Abstract][Full Text] [Related]
4. Binding sites of fluorescent probes on human serum albumin.
Muller N; Lapicque F; Drelon E; Netter P
J Pharm Pharmacol; 1994 Apr; 46(4):300-4. PubMed ID: 7519671
[TBL] [Abstract][Full Text] [Related]
5. Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site.
Thumser AE; Buckland AG; Wilton DC
J Lipid Res; 1998 May; 39(5):1033-8. PubMed ID: 9610770
[TBL] [Abstract][Full Text] [Related]
6. Species differences of serum albumins: I. Drug binding sites.
Kosa T; Maruyama T; Otagiri M
Pharm Res; 1997 Nov; 14(11):1607-12. PubMed ID: 9434282
[TBL] [Abstract][Full Text] [Related]
7. A general, wide-rage spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin.
Epps DE; Raub TJ; Kézdy FJ
Anal Biochem; 1995 May; 227(2):342-50. PubMed ID: 7573956
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of drug binding to human serum albumin: allosteric and competitive inhibition at the benzodiazepine binding site by free fatty acids of various chain lengths.
Menke G; Wörner W; Kratzer W; Rietbrock N
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):42-7. PubMed ID: 2471088
[TBL] [Abstract][Full Text] [Related]
9. Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs.
Taguchi K; Chuang VT; Yamasaki K; Urata Y; Tanaka R; Anraku M; Seo H; Kawai K; Maruyama T; Komatsu T; Otagiri M
J Pharm Pharmacol; 2015 Feb; 67(2):255-63. PubMed ID: 25556343
[TBL] [Abstract][Full Text] [Related]
10. Species differences of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions.
Kosa T; Maruyama T; Sakai N; Yonemura N; Yahara S; Otagiri M
Pharm Res; 1998 Apr; 15(4):592-8. PubMed ID: 9587956
[TBL] [Abstract][Full Text] [Related]
11. Human serum albumin binding assay based on displacement of a non selective fluorescent inhibitor.
Thorarensen A; Sarver RW; Tian F; Ho A; Romero DL; Marotti KR
Bioorg Med Chem Lett; 2007 Aug; 17(16):4646-9. PubMed ID: 17560104
[TBL] [Abstract][Full Text] [Related]
12. Structure of pressure-induced denatured state of human serum albumin: a comparison with the intermediate in urea-induced denaturation.
Tanaka N; Nishizawa H; Kunugi S
Biochim Biophys Acta; 1997 Mar; 1338(1):13-20. PubMed ID: 9074611
[TBL] [Abstract][Full Text] [Related]
13. Binding of sulphamethazine to pig plasma proteins and albumin.
Munsey T; Grigg RE; McCormack A; Symonds HW; Bowmer CJ
J Vet Pharmacol Ther; 1996 Apr; 19(2):135-41. PubMed ID: 8735422
[TBL] [Abstract][Full Text] [Related]
14. The effects of N-B transition of human serum albumin on the specific drug-binding sites.
Wanwimolruk S; Birkett DJ
Biochim Biophys Acta; 1982 Dec; 709(2):247-55. PubMed ID: 6185151
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Ethanol on the Hydrolysis of Ester-Type Drugs by Human Serum Albumin.
Tatsumi A; Inoue S; Hamaguchi T; Iwakawa S
Biol Pharm Bull; 2018 Feb; 41(2):277-280. PubMed ID: 29176265
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence energy transfer study of the relationship between the lone tryptophan residue and drug binding sites in human serum albumin.
Kasai S; Horie T; Mizuma T; Awazu S
J Pharm Sci; 1987 May; 76(5):387-92. PubMed ID: 3656100
[TBL] [Abstract][Full Text] [Related]
17. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
Lautenslager GT; Shearman CW; Hud E; Cohen MP
Metabolism; 2011 Dec; 60(12):1683-91. PubMed ID: 21632076
[TBL] [Abstract][Full Text] [Related]
18. A novel binding site for bile acids on human serum albumin.
Takikawa H; Sugiyama Y; Hanano M; Kurita M; Yoshida H; Sugimoto T
Biochim Biophys Acta; 1987 Nov; 926(2):145-53. PubMed ID: 2444264
[TBL] [Abstract][Full Text] [Related]
19. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
Pistolozzi M; Bertucci C
Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for drug binding to site II on human serum albumin.
Wanwimolruk S; Birkett DJ; Brooks PM
Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
